| COVID-19: characteristics and therapeutics R Chilamakuri, S Agarwal Cells 10 (2), 206, 2021 | 375 | 2021 |
| Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia C Callens, S Coulon, J Naudin, I Radford-Weiss, N Boissel, E Raffoux, ... Journal of Experimental Medicine 207 (4), 731-750, 2010 | 209 | 2010 |
| Neuroblastoma pathogenesis: deregulation of embryonic neural crest development JA Tomolonis, S Agarwal, JM Shohet Cell and tissue research 372 (2), 245-262, 2018 | 140 | 2018 |
| G-CSF promotes neuroblastoma tumorigenicity and metastasis via STAT3-dependent cancer stem cell activation S Agarwal, A Lakoma, Z Chen, J Hicks, L Metelitsa, E Kim Cancer Research, 2015 | 100 | 2015 |
| The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma ESK A Lakoma, E Barbieri, S Agarwal, J Jackson, Z Chen, Y Kim, M McVay, JM ... Cell Death Discovery 1 (doi:10.1038/cddiscovery.2015.26), 15026, 2015 | 89* | 2015 |
| Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia S Coulon, M Dussiot, D Grapton, TT Maciel, PHM Wang, C Callens, ... Nature medicine 17 (11), 1456-1465, 2011 | 83 | 2011 |
| G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic DM Hsu, S Agarwal, A Benham, C Coarfa, DN Trahan, Z Chen, ... Cancer research 73 (13), 4134-4146, 2013 | 74 | 2013 |
| Expression of modified gene encoding functional human α-1-antitrypsin protein in transgenic tomato plants S Agarwal, R Singh, I Sanyal, DV Amla Transgenic research 17, 881-896, 2008 | 74 | 2008 |
| MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma S Zhang, JS Wei, SQ Li, TC Badgett, YK Song, S Agarwal, C Coarfa, ... Cancer letters 371 (2), 214-224, 2016 | 60 | 2016 |
| MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma A Beckers, G Van Peer, DR Carter, M Gartlgruber, C Herrmann, ... Cancer letters 366 (1), 123-132, 2015 | 60 | 2015 |
| Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma MTV Rihani A, Goethem AV, Ongenaert M, Brouwer SD, Volders P, Agarwal S ... Scientific Reports 5, 9027, 2015 | 42 | 2015 |
| MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma S Agarwal, G Milazzo, K Rajapakshe, R Bernardi, Z Chen, E Barberi, ... Oncotarget 9 (29), 20323, 2018 | 37 | 2018 |
| Differential subcellular targeting of recombinant human α1-proteinase inhibitor influences yield, biological activity and in planta stability of the protein in transgenic … S Jha, S Agarwal, I Sanyal, GK Jain, DV Amla Plant science 196, 53-66, 2012 | 33 | 2012 |
| Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma. Agarwal S, Ghosh R, Chen Z, Lakoma A, Gunaratne PH, Kim E, Shohet J Oncotarget, doi: 10.18632/oncotarget.8116, 2016 | 30* | 2016 |
| MELK is a novel therapeutic target in high-risk neuroblastoma S Guan, J Lu, Y Zhao, Y Yu, H Li, Z Chen, Z Shi, H Liang, M Wang, K Guo, ... Oncotarget 9 (2), 2591, 2017 | 27 | 2017 |
| Dual Targeting of PI3K and HDAC by CUDC-907 inhibits pediatric neuroblastoma growth R Chilamakuri, S Agarwal Cancers 14 (4), 1067, 2022 | 23 | 2022 |
| Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling H Li, Y Yu, Y Zhao, D Wu, X Yu, J Lu, Z Chen, H Zhang, Y Hu, Y Zhai, J Su, ... Cancer letters 457, 129-141, 2019 | 22 | 2019 |
| Heterogeneous uptake of nanoparticles in mouse models of pediatric high-risk neuroblastoma KB Ghaghada, ZA Starosolski, A Lakoma, C Kaffes, S Agarwal, ... PloS one 11 (11), e0165877, 2016 | 22 | 2016 |
| Expression and purification of recombinant human α1-proteinase inhibitor and its single amino acid substituted variants in Escherichia coli for enhanced stability and … S Agarwal, S Jha, I Sanyal, DV Amla Journal of biotechnology 147 (1), 64-72, 2010 | 20 | 2010 |
| BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy R Chilamakuri, DC Rouse, Y Yu, AS Kabir, A Muth, J Yang, JM Lipton, ... Translational Oncology 15 (1), 101272, 2022 | 18 | 2022 |
Jason ShohetUniversity of Massachusetts Medical schoolE-mail megerősítve itt: umassmed.edu
